G. Moore et al. / Tetrahedron 60 (2004) 4197–4204
4203
procedure, compound 11b (0.339 g, 1 mmol) and methyl
iodide (0.25 mL, 4 mmol) afforded 0.142 g (40%) of
N-protected compound 12a as a pale yellow solid after
purification by flash chromatography on silica gel (cyclo-
hexane/ethyl acetate 7/3, Rf¼0.3). Mp (ethyl acetate)
1H NMR (CDCl3,
300 MHz) d 1.17 (d, 3H, J¼7.2 Hz), 2.10–2.60 (m, 7H),
3.12 (s, 3H), 6.80 (d, 1H, J¼7.0 Hz), 7.28 (d, 1H,
J¼1.5 Hz), 7.41 (dd, 1H, J¼7.0, 1.5 Hz). 13C NMR
(CDCl3, 75.5 MHz) d 15.4, 28.2, 28.3, 33.4, 34.5, 35.9,
91.5, 125.3, 129.8, 131.7, 132.9, 134.4, 135.7, 136.3, 175.7.
Anal. Calcd for C15H16INO: C, 51.01; H, 4.57; N, 3.97.
Found: C, 51.1; H, 4.7; N, 4.0.
diethyl ester (13b). According to the general procedure,
reaction of sodium hydride (0.088 g, 2 mmol) in dioxane
(1.2 mL) with diethyl malonate (0.34 mL, 2 mmol), cuprous
iodide (0.38 g, 2 mmol) and lactam 12b (0.46 g, 1 mmol)
afforded 0.246 g (50%) of 13b as a pale brown oil after flash
chromatography on silica gel (cyclohexane/ethyl acetate
8/2, Rf¼0.3). IR (KBr) 1674, 1732 cm21. 1H NMR (CDCl3,
300 MHz) d 1.17 (d, 3H, J¼7.0 Hz), 1.24 (m, 6H), 2.02–
2.55 (m, 7H), 3.65 (s, 3H), 4.15 (m, 4H), 4.46 (s, 1H), 4.57
(d, 1H, J¼16.0 Hz), 5.20 (d, 1H, J¼16.0 Hz), 6.63 (d, 2H,
J¼11.0 Hz), 6.83 (d, 2H, J¼11.0 Hz), 7.18 (m, 3H). Anal.
Calcd for C29H33NO6: C, 70.86; H, 6.77; N, 2.85. Found: C,
70.95; H, 6.8; N, 2.9.
136 8C. IR (KBr) 1670 cm21
.
4.4.3. 9-Iodo-1-(4-methoxybenzyl)-3-methyl-3,4,5,6-
tetrahydro-1H-benzo[h]quinolin-2-one (12b). According
to the general procedure, compound 11b (0.339 g, 1 mmol)
and 4-methoxybenzyl chloride (0.205 mL, 1.5 mmol)
afforded 0.176 g (60%) of N-protected compound 12b as a
brown solid after purification by flash chromatography on
silica gel (cyclohexane/ethyl acetate 85/15, Rf¼0.3). Mp
4.6. General procedure for the catalytic hydrogenation
reaction of benzo[h]quinolin-2-ones
The compound to reduce was dissolved in ethanol in a
pressure vessel and palladium on carbon (10%) was added
under nitrogen. The vessel was flushed with hydrogen and
the mixture was stirred for 12 h at 1 bar. The mixture was
filtered on a celite pad and the solvent was removed under
reduced pressure.
(ethyl acetate) 102 8C. IR (KBr) 1667 cm21 1H NMR
.
(CDCl3, 300 MHz) d 1.17 (d, 3H, J¼7.1 Hz), 2.01–2.48 (m,
7H), 3.68 (s, 3H), 4.52 (d, 1H, J¼11.8 Hz), 5.13 (d, 1H,
J¼11.8 Hz), 6.61 (m, 2H), 6.83 (m, 3H), 7.29 (d, 1H,
J¼1.5 Hz), 7.41 (dd, 1H, J¼8.0, 1.5 Hz). 13C NMR (CDCl3,
75.5 MHz) d 15.3, 28.1, 28.3, 33.3, 36.4, 47.4, 55.6, 91.4,
113.9, 127.9, 129.7, 129.8, 130.5, 131.7, 133.0, 133.3,
135.7, 136.4, 159.0, 175.8. Anal. Calcd for C22H22INO2: C,
57.53; H, 4.83; N, 3.05. Found: C, 57.40; H, 4.78. N, 2.99.
4.6.1. 2-[1-(4-Methoxybenzyl)-3-methyl-2-oxo-1,2,3,
4,4a,5,6,10b-octahydro-benzo[h] quinolin-9-yl]-malonic
acid diethyl ester (14). According to the general procedure,
compound 13b (0.49 g, 1 mmol) in ethanol (50 mL)
containing 10% Pd–C (0.245 g) afforded 0.22 g (45%) of
1
crude 14 as a yellow solid. H NMR (CDCl3, 300 MHz) d
1.20 (m, 9H), 1.26 (m, 1H), 1.65 (m, 1H), 1.85 (m, 1H), 1.96
(m, 1H), 2.29 (m, 1H), 2.42 (m, 1H), 2.6–2.8 (m, 2H), 3.65
(s, 3H), 4.11 (m, 4H), 4.21 (m, 1H), 4.45 (s, 1H), 5.65 (m,
2H), 6.68 (m, 2H), 7.05 (m, 5H).
4.5. General procedure for the copper catalysed coupling
reactions with diethyl malonate
To a suspension of sodium hydride (55% dispersion in
mineral oil) in dry dioxane freshly distilled diethyl malonate
was added under nitrogen. Cuprous iodide and the iodo
derivative were then added and the mixture was heated to
reflux for 5 h. After hydrolysis with a small amount of ice-
water, the solvent was removed under reduced pressure and
the residue was dissolved in dichloromethane. After
filtration, the organic extract was washed with a saturated
aqueous solution of sodium thiosulfate. After drying on
magnesium sulfate, the solvent was removed under reduced
pressure.
4.6.2. 3-Methyl-3,4,4a,5,6,10b-hexahydro-1H-benzo[h]-
quinolin-2-one (1b0). According to the general procedure,
compound 9a (0.64 g, 3 mmol) in ethanol (65 mL) contain-
ing 10% Pd–C (0.48 g) afforded 0.52 g (80%) of 1b0 as a
yellow solid after recrystallization from ethyl acetate. Mp
122 8C. IR (KBr) 1670, 3240 cm21 1H NMR (CDCl3,
.
300 MHz) d 1.05 (d, 3H, J¼5.0 Hz), 1.26 (m, 1H), 1.65 (m,
1H), 1.85 (m, 1H), 1.96 (m, 1H), 2.29 (m, 1H), 2.42 (m, 1H),
2.6–2.8 (m, 2H), 4.45 (dd, 1H, J¼5.2, 3.2 Hz), 6.45 (m,
1H), 7.05–7.23 (m, 4H). 13C NMR (CDCl3, 75.5 MHz) d
16.7, 27.1, 27.6, 32.9, 33.6, 35.6, 53.0, 126.9, 127.8, 128.3,
129.2, 136.3, 136.9, 176.2. Anal. Calcd for C14H17NO: C,
78.10; H, 7.96; N, 6.51. Found: C, 78.0; H, 8.0; N, 6.55.
4.5.1. 2-(1,3-Dimethyl-2-oxo-1,2,3,4,5,6-hexahydro-
benzo[h]quinolin-9-yl)-malonic acid diethyl ester (13a).
According to the general procedure, reaction of sodium
hydride (0.088 g, 2 mmol) in dioxane (1.2 mL) with diethyl
malonate (0.34 mL, 2 mmol), cuprous iodide (0.38 g,
2 mmol) and lactam 12a (0.353 g, 1 mmol) afforded
0.154 g (40%) of 13a as a brown oil after flash chromato-
graphy on silica gel (cyclohexane/ethyl acetate 8/2,
4.6.3. 9-Hydroxy-3methyl-3,4,4a,5,6,10b-hexahydro-1H-
benzo[h]quinolin-2-one (16a). According to the general
procedure, compound 9c (0.16 g, 0.5 mmol) in ethanol
(10 mL) containing 10% Pd–C (0.08 g) afforded 0.098 g
1
(85%) of crude 16a as a white solid. H NMR (DMSO-d6,
1
Rf¼0.3). IR (KBr) 1674, 1732 cm21. H NMR (CDCl3,
300 MHz) d 1.02 (d, 3H, J¼7.2 Hz), 1.18 (m, 1H), 1.61 (m,
1H), 1.84 (m, 1H), 1.96 (m, 1H), 2.29 (m, 1H), 2.52 (m, 1H),
2.65 (m, 2H), 4.35 (d, 1H, J¼3.2 Hz), 6.51–6.68 (m, 2H),
6.82 (d, 1H, J¼8.7 Hz).
300 MHz) d 1.16 (m, 9H), 2.15–2.61 (m, 7H), 3.06 (s, 3H),
4.13 (m, 4H), 4.53 (s, 1H), 6.85 (d, 1H, J¼6.5 Hz), 7.30 (s,
1H), 7.40 (d, 1H, J¼6.5 Hz). Anal. Calcd for C22H27NO5:
C, 68.55; H, 7.06; N, 3.63. Found: C, 68.45; H, 6.99; N,
3.70.
4.6.4. Trifluoromethanesulfonic acid 3-methyl-2-oxo-
1,2,3,4,4a,5,6,10b-octahydro-benzo[h]quinolin-9-yl ester
(16b). To a cooled solution (0 8C) of the crude phenol 16a
(0.76 g, 3.28 mmol) in freshly distilled DMF (22 mL)
4.5.2. 2-[1-(4-Methoxybenzyl)-3-methyl-2-oxo-1,2,3,
4,5,6-hexahydrobenzo[h]quinolin-9-yl]malonic acid